Anabolic Therapy in Postmenopausal Osteoporosis

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 24, 2022

Primary Completion Date

October 1, 2027

Study Completion Date

November 1, 2027

Conditions

Postmenopausal Osteoporosis

Interventions

DRUG

Romosozumab

Monthly romosozumab

DRUG

Denosumab

Every 6 months denosumab

Trial Locations (1)

Massachusetts General Hospital, Boston

All Listed Sponsors

lead

Massachusetts General Hospital

OTHER